Evidence map›Paper›PMID 31648514›Full record

ArticleTurkish journal of medical sciences2019

Evaluation of interleukin-23 receptor (IL-23R) gene polymorphisms and serum IL-23 levels in patients with psoriasis

Başak Filiz, Mehmet Yıldırım, Kuyaş Hekimler Öztürk, Fevziye Burcu Şirin, Seda Çelik, İjlal Erturan, Selma Korkmaz, Hikmet Orhan

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Genetic Association Study ofLife (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Human CLAFrontiers in medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Başak FilizDepartment of Dermatology, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyORCID 0000-0003-1253-4221
Mehmet YıldırımDepartment of Dermatology, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyORCID 0000-0003-3373-9074
Kuyaş Hekimler ÖztürkDepartment of Medical Genetics, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyORCID 0000-0002-7075-8875
Fevziye Burcu ŞirinDepartment of Biochemistry, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyORCID 0000-0001-5304-1007
Seda ÇelikDepartment of Biochemistry, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyORCID 0000-0002-0003-0651
İjlal ErturanDepartment of Dermatology, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyORCID 0000-0002-0640-2292
Selma KorkmazDepartment of Dermatology, Faculty of Medicine, Süleyman Demirel University, Isparta, TurkeyORCID 0000-0003-3877-3976
Hikmet OrhanDepartment of Biostatistics and Medical Informatics, Faculty of Medicine, Süleyman Demirel University Isparta, TurkeyORCID 0000-0002-8389-1069
Süleyman Demirel University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: IL-23R gene polymorphisms and the association of these polymorphisms with serum IL-23 levels were investigated in patients with psoriasis in the current study. Materials and methods: Sixty-seven patients with psoriasis who were admitted to our dermatology outpatient clinic and 67 healthy controls were included in the study. Polymorphisms of the IL-23R gene were determined by KASP-PCR method, and serum IL-23 levels were determined by ELISA method. Results: The distribution of IL-23R gene polymorphisms rs2201841, rs11209026, rs7530511, rs1343152, and rs11465804 was not significantly different in the patient and control groups. The AA genotype of the rs2201841 locus in males and the GA genotype in females, as well as the AA genotype of the rs1343152 locus in males and the CA genotype in females, were statistically significant in patients with psoriasis. The mean serum IL-23 level was significantly lower in the patient group (42.62 ± 5.96) compared to the control groups (75.76 ± 13.24). Conclusion: IL-23R gene polymorphisms including rs2201841, rs11209026, rs7530511, rs11465804, and rs1343152 were not found to be significantly related to psoriasis. Different genetic polymorphisms may play a role in the development of psoriasis in female and male populations. Ethnic differences between different populations may have led to differences in the distribution of polymorphisms in the current study with compared to other published studies. Additionally, many different genes, polymorphisms, and environmental factors that have an effect on the development of psoriasis may affect the disease process.

Indexed as

AdultCase-Control StudiesFemaleGenetic Predisposition to DiseaseHumansInterleukin-23MalePolymorphism, Single NucleotidePsoriasisReceptors, InterleukinIL23R protein, humanInterleukin-23Receptors, InterleukinIL-23R gene polymorphismsPsoriasisserum IL-23 levels

Identifiers

PMID31648514
PMCPMC7018327
OpenAlexW2982076210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.